期刊
NON-CODING RNA RESEARCH
卷 7, 期 4, 页码 242-247出版社
KEAI PUBLISHING LTD
DOI: 10.1016/j.ncrna.2022.09.008
关键词
Brain tumors; Glioblastomas; miRNAs; Molecular markers; Diagnostic markers
资金
- Bashkir State Medical University Strategic Academic Leadership program
- [PRIORITY-2030]
This review discusses the role of miRNAs in gliomas and their potential as diagnostic and therapeutic targets.
Gliomas are the most invasive brain tumors characterized by high mortality and recurrence rates. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and resistance to therapy. Modern diagnostics of various forms of malignant brain tumors is carried out mainly by imaging methods, such as magnetic resonance imaging, electroencephalography, positron emission tomography, and tumor biopsy is also used. The disad-vantages of these methods are their inaccuracy and invasiveness, which entails certain risks for the patient's health, so modern science has stepped up the search for more reliable and safe methods for diagnosing gliomas, including the search for novel biomarkers. MicroRNA (miRNAs), a class of small non-coding RNA, perform the most important functions in various biological processes. In recent years, great progress in the study of miRNAs paths associated with the GBM pathogenesis has been achieved. MiRNAs molecules were identified as diagnostic and prognostic biomarkers, and can also serve as therapeutic targets and agents. This review provides current knowledge about the role of miRNAs in the pathogenesis of glial brain tumors, as well as the potential use of miRNAs as diagnostic and therapeutic targets for gliomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据